SeQure Dx

Personalized Diagnostics for Gene Editing Therapies

SeQure Dx is using state-of-the-art gene editing technology to create a diagnostic platform for various indications. While gene editing has been a great tool advancement in biology, it is important to also verify that no off-target edits have been made. The ONE-seq platform is a method to screen for off-target editing and to ensure that on-target gene editing can be achieved. SeQure is integrating ONE-seq into a comprehensive diagnostic portfolio to provide a full assessment and subsequent management of off-target risks to fulfill the promise of gene editing’s therapeutic potential.